Iovance Biotherapeutics, Inc. (0JDK.L)

USD 3.26

(1.52%)

Eps Summary of Iovance Biotherapeutics, Inc.

  • Iovance Biotherapeutics, Inc.'s latest annual eps in 2023 was -1.89 USD , up 24.1% from previous year.
  • Iovance Biotherapeutics, Inc.'s latest quarterly eps in 2024 Q2 was -0.34 USD , up 19.05% from previous quarter.
  • Iovance Biotherapeutics, Inc. reported an annual eps of -2.49 USD in 2022, down -11.66% from previous year.
  • Iovance Biotherapeutics, Inc. reported an annual eps of -2.23 USD in 2021, down -18.62% from previous year.
  • Iovance Biotherapeutics, Inc. reported a quarterly eps of -0.34 USD for 2024 Q2, up 19.05% from previous quarter.
  • Iovance Biotherapeutics, Inc. reported a quarterly eps of -0.47 USD for 2023 Q2, up 6.0% from previous quarter.

Annual Eps Chart of Iovance Biotherapeutics, Inc. (2023 - 2012)

Created with Highcharts 11.1.0YearsEPS201220132014201520162017201820192020202120222023-5 USD-4 USD-3 USD-2 USD-1 USD0 USD

Historical Annual Eps of Iovance Biotherapeutics, Inc. (2023 - 2012)

Year Eps Eps Growth
2023 -1.89 USD 24.1%
2022 -2.49 USD -11.66%
2021 -2.23 USD -18.62%
2020 -1.88 USD -18.24%
2019 -1.59 USD -25.2%
2018 -1.27 USD 9.93%
2017 -1.41 USD -46.87%
2016 -0.96 USD -54.84%
2015 -0.62 USD -29.17%
2014 -0.48 USD 86.17%
2013 -3.47 USD 16.18%
2012 -4.14 USD 0.0%

Peer Eps Comparison of Iovance Biotherapeutics, Inc.

Name Eps Eps Difference
Imunon, Inc. -2.16 USD 12.5%
Homology Medicines, Inc. -7.41 USD 74.494%
uniQure N.V. -6.47 USD 70.788%
Abeona Therapeutics Inc. -2.53 USD 25.296%
Aclaris Therapeutics, Inc. -1.27 USD -48.819%
Agios Pharmaceuticals, Inc. -6.33 USD 70.142%
Amicus Therapeutics, Inc. -0.51 USD -270.588%
Atara Biotherapeutics, Inc. -65.18 USD 97.1%
bluebird bio, Inc. -1.93 USD 2.073%
Blueprint Medicines Corporation -8.37 USD 77.419%
Cara Therapeutics, Inc. -2.19 USD 13.699%
Adicet Bio, Inc. -3.31 USD 42.9%
Dynavax Technologies Corporation -0.05 USD -3710.484%
Editas Medicine, Inc. -2.02 USD 6.436%
Esperion Therapeutics, Inc. -2.03 USD 6.897%
Geron Corporation -0.32 USD -490.625%
Heron Therapeutics, Inc. -0.80 USD -136.25%
Illumina, Inc. -7.35 USD 74.286%
IQVIA Holdings Inc. 7.39 USD 125.575%
Mettler-Toledo International Inc. 36.10 USD 105.235%
Myriad Genetics, Inc. -1.39 USD -35.971%
Neurocrine Biosciences, Inc. 2.56 USD 173.828%
Sarepta Therapeutics, Inc. -5.80 USD 67.414%
Supernus Pharmaceuticals, Inc. 0.02 USD 7942.324%
Verastem, Inc. -3.96 USD 52.273%
Walgreens Boots Alliance, Inc. -10.01 USD 81.119%
Waters Corporation 10.87 USD 117.387%
Vertex Pharmaceuticals Incorporated 14.05 USD 113.452%
Thermo Fisher Scientific Inc. 15.53 USD 112.17%
Biogen Inc. 8.02 USD 123.566%
Nektar Therapeutics -1.45 USD -30.345%
Viking Therapeutics, Inc. -0.91 USD -107.692%
Perrigo Company plc -0.09 USD -1912.78%
Unity Biotechnology, Inc. -2.70 USD 30.0%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 81.668%
BioMarin Pharmaceutical Inc. 0.89 USD 312.36%
Sangamo Therapeutics, Inc. -1.48 USD -27.703%
Evolus, Inc. -1.08 USD -75.0%
Regeneron Pharmaceuticals, Inc. 37.05 USD 105.101%
FibroGen, Inc. -2.92 USD 35.274%
Agilent Technologies, Inc. 4.22 USD 144.787%
OPKO Health, Inc. -0.25 USD -656.0%
Alnylam Pharmaceuticals, Inc. -3.52 USD 46.307%
Exelixis, Inc. 0.65 USD 390.769%
Anavex Life Sciences Corp. -0.60 USD -215.0%
Intellia Therapeutics, Inc. -5.42 USD 65.129%
Zoetis Inc. 5.08 USD 137.205%
Axsome Therapeutics, Inc. -5.27 USD 64.137%
Kala Pharmaceuticals, Inc. -17.35 USD 89.107%
Ionis Pharmaceuticals, Inc. -2.56 USD 26.172%
Corcept Therapeutics Incorporated 1.02 USD 285.294%
Halozyme Therapeutics, Inc. 2.13 USD 188.732%
Insmed Incorporated -5.34 USD 64.607%
TG Therapeutics, Inc. 0.09 USD 2216.461%
Incyte Corporation 2.67 USD 170.787%
Emergent BioSolutions Inc. -14.85 USD 87.273%